Literature DB >> 22164796

Essential oil analysis and antibacterial activity of Rosmarinus tournefortii from Algeria.

Mansouria Souria Bendeddouche1, Hachemi Benhassaini, Zouaoui Hazem, Abderrahmane Romane.   

Abstract

The volatile compounds obtained by hydrodistillation of the aerial parts of Rosmarinus tournefortii De Noé. growing wild in the occidental region of Algeria were analyzed by GC/MS. Thirty-six compounds were characterized representing 95.6% of the essential oil, with camphor (37.6%), 1,8-cineole (10.0%), p-cymene-7-ol (7.8%), and borneol (5.4%) as the major components. The antimicrobial activity was evaluated against three pathogenic bacteria: Gram-negative (Escherichia coli and Pseudomonas aeruginosa) and Gram-positive (Staphylococcus aureus). The minimum inhibitory concentration (MIC; mg/mL) was determined by sub-culture on Muller Hinton agar plates. The essential oil exhibited strong antibacterial activity against E. coli and P. aeruginosa, and was also active against Staphylococcus aureus.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22164796

Source DB:  PubMed          Journal:  Nat Prod Commun        ISSN: 1555-9475            Impact factor:   0.986


  3 in total

1.  Boiling Technique-Based Food Processing Effects on the Bioactive and Antimicrobial Properties of Basil and Rosemary.

Authors:  Ahmad Mohammad Salamatullah; Khizar Hayat; Shaista Arzoo; Abdulhakeem Alzahrani; Mohammed Asif Ahmed; Hany M Yehia; Tawfiq Alsulami; Nawal Al-Badr; Bandar Ali M Al-Zaied; Mohammed Musaad Althbiti
Journal:  Molecules       Date:  2021-12-04       Impact factor: 4.411

2.  The potential of use basil and rosemary essential oils as effective antibacterial agents.

Authors:  Monika Sienkiewicz; Monika Łysakowska; Marta Pastuszka; Wojciech Bienias; Edward Kowalczyk
Journal:  Molecules       Date:  2013-08-05       Impact factor: 4.411

Review 3.  Antioxidant and Antimicrobial Properties of Rosemary (Rosmarinus officinalis, L.): A Review.

Authors:  Gema Nieto; Gaspar Ros; Julián Castillo
Journal:  Medicines (Basel)       Date:  2018-09-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.